Protein engineering toolset boosts efficacy of CAR-T cells targeting blood and solid cancers

Cancer researchers focused on improving the success of cancer immunotherapies introduced a new tool in a Yale study published in Nature Chemical Biology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup